Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | CDC25B | P30305 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17607589 | 0.92 | LMNA (0.43) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL17607493 | 0.90 | LMNA (0.42) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL28794358 | 0.90 | LMNA (0.42) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL1971821 | 0.82 | — | — | |
| SCHEMBL28621256 | 0.81 | MEN1 (0.50) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL7708604 | 0.81 | MEN1 (0.32) | MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL19545639 | 0.79 | MEN1 (0.39) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL17607530 | 0.79 | MEN1 (0.31) | MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL306062 | 0.79 | LMNA (0.48) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL29200722 | 0.78 | MEN1 (0.47) | MEN1CYP3A4ALOX15KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7312249-B2 | Vitamin D analogues | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2007-12-25 | — | — | US | claimed |
| US-20050182144-A1 | Novel vitamin D analogues | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2005-08-18 | — | — | US | claimed |
| US-4142983-A | PHTHALATE MIXTURES USEFUL AS LIQUID DIELECTRICS | RHONE-POULENC INDUSTRIES (FR) | 1979-03-06 | — | — | US | claimed |
| CN-117865922-A | Formylcarboxylate coumarin compounds, methods of preparation and use thereof, and photoinitiator compositions containing same | 湖北固润科技股份有限公司 | 2024-04-12 | — | — | CN | disclosed |
| CN-113347880-B | Safety compositions comprising a pyridine carboxylate herbicide and a bisbenzoxazole acid | 科迪华农业科技有限责任公司 | 2023-02-17 | — | — | CN | disclosed |
| CN-111278846-A | Antimicrobial tetrapeptides | 帝斯曼知识产权资产管理有限公司 | 2020-06-12 | — | — | CN | disclosed |
| CN-107074757-B | The manufacturing method of trifluoromethyl alkylthio chemical combination object | 组合化学工业株式会社 | 2019-05-03 | — | — | CN | disclosed |
| CN-105969543-B | Flue dust cleaning agent after fire | 江苏筑磊电子科技有限公司 | 2019-04-05 | — | — | CN | disclosed |
| CN-107108518-A | Antibacterial imidazolium compounds | 新加坡科技研究局 | 2017-08-29 | — | — | CN | disclosed |
| CN-107074757-A | The manufacture method of trifluoromethyl alkylthio compound | 组合化学工业株式会社 | 2017-08-18 | — | — | CN | disclosed |
| CN-105969543-A | Smoke dust cleaning agent after fire hazards | 江苏筑磊电子科技有限公司 | 2016-09-28 | — | — | CN | disclosed |
| US-20020019353-A1 | Use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals | CANNING PETER CONNOR (US) | 2002-02-14 | — | — | US | disclosed |
| US-5201937-A | SALICYCLIC ACID DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 1993-04-13 | — | — | US | disclosed |
| EP-0151282-B1 | OPTICALLY ACTIVE 3,4-BIS-(DIPHENYLPHOSPHINO)-PYRROLIDINE, RHODIUM COMPLEXES CONTAINING THEM AS CHIRAL LIGANDS, AND THEIR USE | Degussa Aktiengesellschaft (DE) | 1988-09-07 | — | — | EP | disclosed |
| EP-0151282-A1 | Optically active 3,4-bis-(diphenylphosphino)-pyrrolidine, rhodium complexes containing them as chiral ligands, and their use | Degussa Aktiengesellschaft (DE) | 1985-08-14 | — | — | EP | disclosed |
| US-4142983-A | PHTHALATE MIXTURES USEFUL AS LIQUID DIELECTRICS | RHONE-POULENC INDUSTRIES (FR) | 1979-03-06 | — | — | US | disclosed |
| US-4097521-A | Manufacture of amidosulfonic acids | BASF AKTIENGESELLSCHAFT (DT) | 1978-06-27 | — | — | US | disclosed |
| US-4083849-A | Process for preparation of 5-cyanopyrid-6-ones | BASF AKTIENGESELLSCHAFT (DT) | 1978-04-11 | — | — | US | disclosed |
| US-4026940-A | CLEAVING TERT-BUTYL ESTER WITH STRONG ACID | TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) | 1977-05-31 | — | — | US | disclosed |
| US-3954826-A | ANTIBACTERIAL INTERMEDIATES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019353-A1 | Use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals | PIGS, AZI2, AADAC | MEN1 2400/4885CYP3A4 215/4885ALOX15 1747/4885 |
| US-20050182144-A1 | Novel vitamin D analogues | CYP24A1, CYP2R1, VDR | MEN1 1405/4885CYP3A4 305/4885ALOX15 530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.